Search
Add filters:
Use filters to refine the search results.
Results 1-10 of 10 (Search time: 0.005 seconds).
- previous
- 1
- next
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| 18-Sep-2019 | Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial | Adamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; González Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix |
| 7-Apr-2021 | Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer | Schettini, Francesco; Barbao, P; Brasó Maristany, Fara; Galván, Patricia; Martínez, Debora; Paré, Laia; Placido, Sabino De; Prat Aparicio, Aleix; Guedán Carrió, Sònia |
| 30-Mar-2021 | RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer | Sanz Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomás; Galván, Patricia; Benítez, Sandra; Gómez Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sònia; Petit, Anna; Soler, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Mulder, Celine; Lemeer, Simone; Arribas, Joaquín V. (Vicente); Prat Aparicio, Aleix; Puig, Teresa; González Suárez, Eva |
| 10-Jan-2023 | Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study | García Corbacho, Javier; Indacochea, Alberto; González Navarro, Azucena E.; Victoria, Iván; Moreno, Debora; Pesantez, David; Angelats, Laura; Modrego Sanchez, Andrea; Sanfeliu, Esther; Castillo, Oleguer; Blasco, Paula; Mezquita, Laura; Viñolas Segarra, Núria; Nogué, Miquel; Galván, Patricia; Adamo, Barbara; Basté, Neus; Saurí, Tamara; Juan Manel; Prat Aparicio, Aleix; Schettini, Francesco |
| May-2017 | Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating population | Gómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra Elizalde, Violeta; Prat Aparicio, Aleix; González Suárez, Eva |
| 3-Jan-2022 | Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer | Prat Aparicio, Aleix; Guarneri, Valentina; Pascual, Tomás; Brasó Maristany, Fara; Sanfeliu, Esther; Paré Brunet, Laia; Schettini, Francesco; Martínez, Debora; Jares Gerboles, Pedro; Griguolo, Gaia; Dieci, Maria Vittoria; Cortés, Javier; Llombart Cussac, Antonio; Conte, Benedetta; Marín Aguilera, Mercedes; Chic Ruché, Núria; Puig Butillé, Joan Anton; Martínez, Antonio; Galván, Patricia; Tsai, Yi-Hsuan; González Farré, Blanca; Mira, Aurea; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Conte, Pierfranco; Perou, Charles M. |
| 14-Jul-2020 | ERBB2mRNA expression and response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-positive breast cancer | Griguolo, Gaia; Brasó Maristany, Fara; González Farré, Blanca; Pascual, Tomás; Chic Ruché, Núria; Saurí, Tamara; Kates, Ronald; Gluz, Oleg; Martínez, Débora; Paré, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz Mateu, Montserrat; Galván, Patricia; Barberá, Laura; Cuatrecasas Freixas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge Escartín, Inés; Villagrasa, Patricia; Soy Muner, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat Aparicio, Aleix |
| 13-May-2020 | Frequency and spectrum of PIK3CA somatic mutations in breast cancer | Martínez Sáez, Olga; Chic Ruché, Núria; Pascual, Tomás; Adamo, Barbara; Vidal Losada, Maria Jesús; Gonzalez-Farre, Xavier; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Brasó Maristany, Fara; Rodriguez, Adela; Martínez, Debora; Galván, Patricia; Rodríguez, Ana Belén; Martínez, Antonio; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |
| Dec-2022 | HER2DX ERBB2 mRNA expression in advanced HER2- positive breast cancer treated with T-DM1 | Brasó Maristany, Fara; Griguolo, Gaia; Chic Ruché, Núria; Pascual, Tomás; Paré Brunet, Laia; Maues, Julia; Galván, Patricia; Dieci, Maria Vittoria; Miglietta, Federica; Giarratano, Tommaso; Martínez Sáez, Olga; Marín Aguilera, Mercedes; Schettini, Francesco; Conte, Benedetta; Angelats, Laura; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz, Montse; Sanfeliu, Esther; González Farré, Blanca; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Conte, Pierfranco; Prat Aparicio, Aleix; Guarneri, Valentina |
| 19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic Ruché, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
Discover
Subject